Tokyo Tape
Sign in
← Perseus Proteomics

Annual report

4882.TEDINET S100OCLP
Period2021-04-01 → 2022-03-31
Filed2022-06-23
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 76
MetricValuePeriodScopeSource row
Revenue¥72m2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥68m2020-04-01 → 2021-03-31StandaloneNet sales
Revenue¥86m2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥276m2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Revenue¥304m2017-04-01 → 2018-03-31dStandaloneNet sales (5-year summary)
Operating income−¥472m2021-04-01 → 2022-03-31StandaloneOperating income
Operating income−¥412m2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income−¥482m2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income−¥410m2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income−¥834m2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥146m2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥164m2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥597m2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax−¥411m2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income−¥599m2021-04-01 → 2022-03-31StandaloneProfit loss
Net income−¥413m2020-04-01 → 2021-03-31StandaloneProfit loss
Net income−¥842m2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income−¥163m2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income−¥178m2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥3.3bnat 2022-03-31StandaloneAssets
Total assets¥1.1bnat 2021-03-31StandaloneAssets
Total assets¥548mat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.4bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.5bnat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥148mat 2022-03-31StandaloneLiabilities
Total liabilities¥35mat 2021-03-31StandaloneLiabilities
Net assets / equity¥3.2bnat 2022-03-31StandaloneNet assets
Net assets / equity¥1.1bnat 2021-03-31StandaloneNet assets
Net assets / equity¥486mat 2020-03-31dStandaloneNet assets
Net assets / equity¥1.3bnat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.5bnat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥3.2bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥1.1bnat 2021-03-31StandaloneCash and deposits
Cash & equivalents¥3.2bnat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2021-03-31StandaloneCash and cash equivalents
Cash & equivalents¥482mat 2020-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2019-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.4bnat 2018-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥477m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥423m2020-04-01 → 2021-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥609m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥330m2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥132m2017-04-01 → 2018-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥34m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥3m2020-04-01 → 2021-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥3m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥16m2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥11m2017-04-01 → 2018-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥2.6bn2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.0bn2020-04-01 → 2021-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.4bn2017-04-01 → 2018-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-54.472021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-59.032020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-136.952019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-26.532018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-2,072.472017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥268.05at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥128.86at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥79.05at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥216at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥7,275.85at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio95.5%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio96.6%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio88.7%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio97.6%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio98.4%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued11,759,400at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued8,386,400at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued6,146,400at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued204,880at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued204,880at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees21at 2022-03-31StandaloneNumber of employees
Employees19at 2021-03-31StandaloneNumber of employees
Employees21at 2020-03-31dStandaloneNumber of employees
Employees23at 2019-03-31dStandaloneNumber of employees
Employees20at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 725
ItemContextValueUnit
Net cash provided by used in financing activitiesCurrentYearDuration_NonConsolidatedMember2647548000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember1456000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember8714000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember586835000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember2145552000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember482464000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1069300000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember1069300000JPY
Cash and cash equivalentsCurrentYearInstant_NonConsolidatedMember3214852000JPY
Salaries and allowances sgaPrior1YearDuration_NonConsolidatedMember34773000JPY
Salaries and allowances sgaCurrentYearDuration_NonConsolidatedMember35711000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember313398000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember308424000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodPrior1YearDuration_NonConsolidatedMember313398000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodCurrentYearDuration_NonConsolidatedMember308424000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-06-23
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第22期（自　2021年４月１日　至　2022年３月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社ペルセウスプロテオミクス
Company name in english cover pageFilingDateInstantPerseus Proteomics Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長執行役員　　横川　拓哉
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都目黒区駒場四丁目７番６号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03-5738-1705（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役執行役員管理部長　　鈴川　信一
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都目黒区駒場四丁目７番６号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03-5738-1705（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役執行役員管理部長　　鈴川　信一
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE35510
Fund codeFilingDateInstant－
Security codeFilingDateInstant48820
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社ペルセウスプロテオミクス
Filer name in englishFilingDateInstantPerseus Proteomics Inc.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第三号様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Current fiscal year start dateFilingDateInstant2021-04-01
Current period end dateFilingDateInstant2022-03-31
Type of current periodFilingDateInstantFY
Current fiscal year end dateFilingDateInstant2022-03-31
Previous fiscal year start dateFilingDateInstant2020-04-01
Comparative period end dateFilingDateInstant2021-03-31
Previous fiscal year end dateFilingDateInstant2021-03-31

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2021-03-31pass rounding
balance sheet identitynon_consolidated 2022-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · operating cash flownon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass